243 related articles for article (PubMed ID: 12900280)
21. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
[TBL] [Abstract][Full Text] [Related]
22. Evidence for immunodominance between closely related epitopes in the selection of T cell repertoire: hierarchy of T cell epitopes in a repeating sequence.
Novak Z; Fraga E; Singh B
Mol Immunol; 1992 Dec; 29(12):1467-76. PubMed ID: 1454065
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of immunodominance in T-cell recognition, with applications to vaccine design.
Berzofsky JA
Princess Takamatsu Symp; 1988; 19():161-77. PubMed ID: 2479631
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
25. The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation.
Sette A; Livingston B; McKinney D; Appella E; Fikes J; Sidney J; Newman M; Chesnut R
Biologicals; 2001; 29(3-4):271-6. PubMed ID: 11851327
[TBL] [Abstract][Full Text] [Related]
26. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
[TBL] [Abstract][Full Text] [Related]
27. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
[TBL] [Abstract][Full Text] [Related]
28. The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.
Palmowski M; Salio M; Dunbar RP; Cerundolo V
Immunol Rev; 2002 Oct; 188():155-63. PubMed ID: 12445289
[TBL] [Abstract][Full Text] [Related]
29. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.
Moore AC; Gallimore A; Draper SJ; Watkins KR; Gilbert SC; Hill AV
J Immunol; 2005 Dec; 175(11):7264-73. PubMed ID: 16301631
[TBL] [Abstract][Full Text] [Related]
30. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
31. Current methods of epitope identification for cancer vaccine design.
Cherryholmes GA; Stanton SE; Disis ML
Vaccine; 2015 Dec; 33(51):7408-7414. PubMed ID: 26238725
[TBL] [Abstract][Full Text] [Related]
32. Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production.
Oyarzún P; Kobe B
Hum Vaccin Immunother; 2016 Mar; 12(3):763-7. PubMed ID: 26430814
[TBL] [Abstract][Full Text] [Related]
33. Immune epitope mapping in the post-genomic era: lessons for vaccine development.
Sette A; Peters B
Curr Opin Immunol; 2007 Feb; 19(1):106-10. PubMed ID: 17113275
[TBL] [Abstract][Full Text] [Related]
34. Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection.
Yang HJ; Zhang JY; Wei C; Yang LY; Zuo QF; Zhuang Y; Feng YJ; Srinivas S; Zeng H; Zou QM
PLoS One; 2016; 11(2):e0149638. PubMed ID: 26895191
[TBL] [Abstract][Full Text] [Related]
35. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella.
Verma NK; Ziegler HK; Wilson M; Khan M; Safley S; Stocker BA; Schoolnik GK
Vaccine; 1995 Feb; 13(2):142-50. PubMed ID: 7625107
[TBL] [Abstract][Full Text] [Related]
36. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
[TBL] [Abstract][Full Text] [Related]
37. Variable epitope library-based vaccines: shooting moving targets.
Pedroza-Roldan C; Charles-Niño C; Saavedra R; Govezensky T; Vaca L; Avaniss-Aghajani E; Gevorkian G; Manoutcharian K
Mol Immunol; 2009 Dec; 47(2-3):270-82. PubMed ID: 19853920
[TBL] [Abstract][Full Text] [Related]
38. Antigen-presenting cells and the selection of immunodominant epitopes.
Blum JS; Ma C; Kovats S
Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428
[TBL] [Abstract][Full Text] [Related]
39. Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.
Agallou M; Margaroni M; Athanasiou E; Toubanaki DK; Kontonikola K; Karidi K; Kammona O; Kiparissides C; Karagouni E
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005311. PubMed ID: 28114333
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic T cell polyepitope vaccines delivered by ISCOMs.
Le TT; Drane D; Malliaros J; Cox JC; Rothel L; Pearse M; Woodberry T; Gardner J; Suhrbier A
Vaccine; 2001 Sep; 19(32):4669-75. PubMed ID: 11535315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
